Spencer David M.
Chief Technology Officer at BELLICUM PHARMACEUTICALS, INC
- Sold, on record
- $1.9M
- Dollars the filings state
- Form 4 sales
- 12
- Latest Sep 4, 2018
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- BELLICUM PHARMACEUTICALS, INCChief Technology Officer
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale BELLICUM PHARMACEUTICALS, INCPlan not statedAug 15, 2016 2016
Sold 1,000 shares at $20.00 ($20k)
Spencer David M., Chief Scientific Officer
Sold 0.6% of holdings ($3.5M position)175,082 shares left0.1x usual sizeFiling
- 2 Form 4 sale BELLICUM PHARMACEUTICALS, INCPlan not statedSep 20, 2016 +36 days
Sold 2,500 shares at $20.01 ($50k)
Spencer David M., Chief Scientific Officer
Sold 1.4% of holdings ($3.5M position)172,582 shares left0.5x usual sizeFiling
- 3 Form 4 sale BELLICUM PHARMACEUTICALS, INCUnusualSep 23, 2016 +3 days
Sold 16,500 shares at $19.88 ($328k)
Spencer David M., Chief Scientific Officer
Sold 9.6% of holdings ($3.4M position)156,082 shares left3.3x usual sizeFiling
- 4 Form 4 sale BELLICUM PHARMACEUTICALS, INCPlan not statedDec 1, 2016 +69 days
Sold 5,000 shares at $17.52 ($88k)
Spencer David M., Chief Scientific Officer
Sold 3.2% of holdings ($2.7M position)151,082 shares left1x usual sizeFiling
- 5 Form 4 sale BELLICUM PHARMACEUTICALS, INCPlan not statedDec 5, 2016 +4 days
Sold 5,000 shares at $20.00 ($100k)
Spencer David M., Chief Scientific Officer
Sold 3.3% of holdings ($3M position)146,082 shares left1x usual sizeFiling
- 6 Form 4 sale BELLICUM PHARMACEUTICALS, INCPlan not statedJul 10, 2017 +217 days
Sold 10,000 shares at $11.54 ($115k)
Spencer David M., Chief Scientific Officer
Sold 6.7% of holdings ($1.7M position)138,965 shares left2x usual sizeFiling
- 7 Form 4 sale BELLICUM PHARMACEUTICALS, INCUnusualJul 18, 2018 +373 days
Sold 40,000 shares at $7.63 ($305k)
Spencer David M., Chief Technology Officer
Sold 28.6% of holdings ($1.1M position)99,939 shares left8x usual sizeFiling
- 8 Form 4 sale BELLICUM PHARMACEUTICALS, INCPlan not statedSep 4, 2018 +48 days
Sold 10,000 shares at $7.04 ($70k)
Spencer David M., Chief Technology Officer
Sold 10% of holdings ($704k position)89,939 shares left1.3x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (12)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Sep 4, 2018 | Sep 5, 2018 | BELLICUM PHARMACEUTICALS, INC | Chief Technology Officer | Form 4 sale | 10,000 | $70k | 10.0% | Plan not stated | SEC |
| Jul 18, 2018 | Jul 20, 2018 | BELLICUM PHARMACEUTICALS, INC | Chief Technology Officer | Form 4 sale | 40,000 | $305k | 28.6% | Unusual | SEC |
| Jul 10, 2017 | Jul 12, 2017 | BELLICUM PHARMACEUTICALS, INC | Chief Scientific Officer | Form 4 sale | 10,000 | $115k | 6.7% | Plan not stated | SEC |
| Dec 5, 2016 | Dec 5, 2016 | BELLICUM PHARMACEUTICALS, INC | Chief Scientific Officer | Form 4 sale | 5,000 | $100k | 3.3% | Plan not stated | SEC |
| Dec 1, 2016 | Dec 5, 2016 | BELLICUM PHARMACEUTICALS, INC | Chief Scientific Officer | Form 4 sale | 5,000 | $88k | 3.2% | Plan not stated | SEC |
| Sep 23, 2016 | Sep 23, 2016 | BELLICUM PHARMACEUTICALS, INC | Chief Scientific Officer | Form 4 sale | 16,500 | $328k | 9.6% | Unusual | SEC |
| Sep 20, 2016 | Sep 20, 2016 | BELLICUM PHARMACEUTICALS, INC | Chief Scientific Officer | Form 4 sale | 2,500 | $50k | 1.4% | Plan not stated | SEC |
| Aug 15, 2016 | Aug 17, 2016 | BELLICUM PHARMACEUTICALS, INC | Chief Scientific Officer | Form 4 sale | 1,000 | $20k | 0.6% | Plan not stated | SEC |
| Jul 27, 2016 | Jul 29, 2016 | BELLICUM PHARMACEUTICALS, INC | Chief Scientific Officer | Form 4 sale | 10,000 | $150k | 5.4% | Plan not stated | SEC |
| Dec 1, 2015 | Dec 3, 2015 | BELLICUM PHARMACEUTICALS, INC | Chief Scientific Officer | Form 4 sale | 5,000 | $115k | 2.7% | Plan not stated | SEC |
| Sep 11, 2015 | Sep 15, 2015 | BELLICUM PHARMACEUTICALS, INC | Chief Scientific Officer | Form 4 sale | 5,000 | $95k | 2.7% | Plan not stated | SEC |
| Jun 16, 2015 | Jun 18, 2015 | BELLICUM PHARMACEUTICALS, INC | Chief Scientific Officer | Form 4 sale | 20,000 | $459k | 10.9% | Plan not stated | SEC |